100s of titles, one news app for just $10 a month.
Dive Deeper:
Orchard Therapeutics: Q1 Earnings Insights
Orchard Therapeutics (NASDAQ:ORTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need…
Panbela Therapeutics: Q1 Earnings Insights
Panbela Therapeutics (NASDAQ:PBLA) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:15 PM. Here's what investors need…
CymaBay Therapeutics: Q1 Earnings Insights
CymaBay Therapeutics (NASDAQ:CBAY) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need…
Applied Therapeutics: Q1 Earnings Insights
Applied Therapeutics (NASDAQ:APLT) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need…
One subscription that gives you access to news from hundreds of sites
Chemomab Therapeutics: Q1 Earnings Insights
Chemomab Therapeutics (NASDAQ:CMMB) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:00 AM. Here's what investors need…
Abeona Therapeutics: Q1 Earnings Insights
Abeona Therapeutics (NASDAQ:ABEO) reported its Q1 earnings results on Friday, May 13, 2022 at 07:30 AM. Here's what investors need…
Get all your news in one place
Latest Business news:
Clearview AI cops $13m fine in the UK, with help from Australia
Controversial facial recognition firm Clearview AI has been handed a $13.3 million fine by the UK privacy watchdog following a…
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
Samsung commits $356 bn in investments with 80,000 new jobs
Seoul (AFP) - Samsung Group on Tuesday unveiled a massive 450 trillion won ($356 billion) investment blueprint for the next…
NSW government announces subsidy for waterlogged North Coast timber industry
Timber mills in Northern NSW have had to look further and further afield for wood in the wake of flooding…
Aust 'back on the map' for green investors
The prospect of a government with more ambitious climate and energy transition plans has put Australia back on the map…
Putin’s State Oil Champion Suffers Biggest Production Drop
The state-run oil champion led by a close ally of President Vladimir Putin has seen the largest drop in production…
From analysis to good news, read the world’s best news in one place
Davos booster for $18 billion fund to fight AIDS, tuberculosis and malaria
A global health fund has raised a third of the $18 billion it says is needed to reverse setbacks caused…
World’s top fertiliser maker sees two years of high prices
In more bad news for farmers, a fertiliser that's key for crop production across the world will remain expensive for…

vTv Therapeutics: Q1 Earnings Insights

By Benzinga Insights

 

vTv Therapeutics (NASDAQ:VTVT) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:45 AM.

Here's what investors need to know about the announcement.

Earnings

vTv Therapeutics missed estimated earnings by 25.0%, reporting an EPS of $-0.1 versus an estimate of $-0.08.

Revenue was up $1.01 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 0.37% increase in the share price the next day.

Here's a look at vTv Therapeutics's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.07 -0.06 -0.07 -0.06
EPS Actual -0.11 -0.02 -0.01 -0.09
Revenue Estimate 1.00M 2.80M 1.00M 987.00K
Revenue Actual 9.00K 3.00M 9.00K 987.00K

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for vTv Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.

Dive Deeper:
Orchard Therapeutics: Q1 Earnings Insights
Orchard Therapeutics (NASDAQ:ORTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need…
Panbela Therapeutics: Q1 Earnings Insights
Panbela Therapeutics (NASDAQ:PBLA) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:15 PM. Here's what investors need…
CymaBay Therapeutics: Q1 Earnings Insights
CymaBay Therapeutics (NASDAQ:CBAY) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need…
Applied Therapeutics: Q1 Earnings Insights
Applied Therapeutics (NASDAQ:APLT) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need…
One subscription that gives you access to news from hundreds of sites
Chemomab Therapeutics: Q1 Earnings Insights
Chemomab Therapeutics (NASDAQ:CMMB) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:00 AM. Here's what investors need…
Abeona Therapeutics: Q1 Earnings Insights
Abeona Therapeutics (NASDAQ:ABEO) reported its Q1 earnings results on Friday, May 13, 2022 at 07:30 AM. Here's what investors need…
Get all your news in one place